The non-neoplastic kidney in tumor nephrectomy specimens: What can it show and what is important?

Advances in Anatomic Pathology

Volumn 17, Issue 4, 2010, Pages 235-250

  Bonsib, Stephen M ^a   Pei, Ying ^a  

^a Louisiana State University School of Medicine Shreveport   (United States)

Author keywords

chronic kidney disease; nephrectomy; nephrogenic rests; non neoplastic kidney; renal cell carcinoma; renal cystic disease; Wilms tumor

Indexed keywords

ARTERY DISEASE; CANCER INCIDENCE; CANCER RISK; CHRONIC KIDNEY DISEASE; DENYS DRASH SYNDROME; DIABETIC NEPHROPATHY; DISEASE ASSOCIATION; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; KIDNEY CAPSULE; KIDNEY CORTEX; KIDNEY POLYCYSTIC DISEASE; KIDNEY TUMOR; LYMPHANGIOGENESIS; MESANGIUM CELL; METASTASIS; NEPHRECTOMY; NEPHROBLASTOMA; NEPHROSCLEROSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK ASSESSMENT; SURGICAL TECHNIQUE; URINARY DYSFUNCTION; VASCULAR DISEASE;

ADULT; ARTERIOSCLEROSIS; CHILD; CHRONIC DISEASE; DIABETES COMPLICATIONS; HUMANS; KIDNEY; KIDNEY DISEASES; KIDNEY DISEASES, CYSTIC; KIDNEY NEOPLASMS; LYMPHANGIOGENESIS; NEPHRECTOMY; NEPHROSCLEROSIS; WILMS TUMOR;

EID: 77954505326     PISSN: 10724109     EISSN: 15334031     Source Type: Journal    
DOI: 10.1097/PAP.0b013e3181e3c02d     Document Type: Review

References (134)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2009. CA Cancer J Clin. 2009;59:225-249.
2. Weiss RH, Lin PY. Kidney cancer: identification of novel targets for therapy. Kidney cancer: identification of novel targets for therapy. Kidney Int. 2006;69:224-232.
3. Iliopoulos O. Molecular biology of renal cell cancer and the identification of therapeutic targets. J Clin Oncol. 2006;24:5593-5600. (Pubitemid 46631340)
4. Brugarolas J. Renal-cell carcinoma-molecular pathways and therapies. N Engl J Med. 2007;356:185-187.
5. Costa LJ, Drabkin HA. Renal cell carcinoma: new developments in molecular biology and potential for targeted therapies. Oncologist. 2007;12:1404-1415.
6. Hanna SC, Heathcote SA, Kim WY. mTOR pathway in renal cell carcinoma. Expert Rev Anticancer Ther. 2008;8:282-393.
7. Escudier B, Eisen T, Stadler WM, et al.; for the TARGET Study Group. Sorafenib in advanced clear-cell renal-cell carcinoma. N Engl J Med. 2009;356:125-134.
8. Lau WKO, Blute ML, Weaver AL, et al. Matched comparison of radical nephrectomy versus nephron sparing surgery in patients with unilateral renal cell carcinoma and a normal contralateral kidney. Mayo Clin Proc. 2005;75: 1236-1242.
9. Huang WC, Levey AS, Serio AM, et al. Chronic kidney disease after nephrectomy in patients with renal cortical tumors: a retrospective cohort study. Lancet Oncol. 2006;7:735-740.
10. Zorn KC, Gong EM, Ovieto MA, et al. Comparison of laparoscopic radical and partial nephrectomy: effects on long-term serum creatinine. Urology. 2007;69:1035-1140.
11. Thompson RH, Boorjian SA, Lohse CM, et al. Radical nephrectomy for pT1a renal masses may be associated with decreased overall patient survival compared with partial nephrectomy. J Urol. 2008;179:468-473.
12. Huang WC, Elkin EB, Levey AS, et al. Partial nephrectomy versus radical nephrectomy in patients with small renal tumors-is there a difference in mortality and cardiovascular outcomes. J Urol. 2009;181:55-62.
13. Sharma N, O'Hara J, Novick AC, et al. Correlation between loss of renal function and loss of renal volume after partial nephrectomy for tumor in a solitary kidney. J Urol. 2008;179:1284-1288.
14. Weight CJ, Larson BT, Fergany AF, et al. Nephrectomy induced chronic renal insufficiency is associated with increased risk of cardiovascular death and death from any cause with localized cT1b renal masses. J Urol. 2010;183:1317-1323.
15. McKiernan J, Simmons R, Katz J, et al. Natural history of chronic renal insufficiency after partial and radical nephrect-omy. Urology. 2002;59:816-820. (Pubitemid 34522166)
16. Jeon HG, Jeong IG, Lee JW, et al. Prognostic factors for chronic kidney disease after curative surgery in patients with small renal tumors. Urology. 2009;74:1064-1069.
17. Peycelon M, Hupertan V, Comperat E, et al. Long-term outcomes after nephron sparing surgery for renal cell carcinoma larger than 4cm. J Urol. 2009;181:35-41.
18. Thompson R, Siddiqui S, Lohse CM, et al. Partial versus radical nephrectomy for 4 to 7cm renal cortical tumors. J Urol. 2009;182:2601-2606.
19. Perlman EJ, Grosfeld JL, Togashi K, et al. Nephroblastoma. In: Eble JN, Sauter G, Epstein JI, et al. eds. The WHO Classification of Tumours of the Urinary System and Male Genital Organs. Lyon: IARC; 2004:48-52.
20. D'Angio GJ. The National Wilms Tumor Study: a 40 year perspective. Lifetime Data Anal. 2007;13:463-470.
21. Weight CJ, Kaouk JH, Hegarty NJ, et al. Correlation of radiographic imaging and histopathology following cryoabla-tion and radio frequency ablation for renal tumors. J Urol. 2008;179:1277-1283.
22. Kunkle DA, Egleston BL, Uzzo RG. Excise, ablate or observe: the small renal mass dilemma-a meta-analysis and review. J Urol. 2008;179:1227-1234.
23. National Kidney Foundation. K/DOQI Clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Am J Kidney Dis. 2002;39:S1-S266.
24. Levey AS, Eckardt K-U, Tsukamoto Y, et al. Definition and classification of chronic kidney disease: a position statement from Kidney Disease Improving Global Outcomes (KDIGO). Kidney Int. 2005;67:2089-2100. (Pubitemid 41623371)
25. Coresh J, Selvin E, Stevens L, et al. Prevalence of chronic kidney disease in the United States. JAMA. 2007;298:2038-2047. (Pubitemid 350074801)
26. Eble JN, Togashi K, Pisani P. Renal cell carcinoma. In: Eble JN, Sauter G, Epstein JI, et al. eds. The WHO Classification of Tumours of the Urinary System and Male Genital Organs. Lyon: IARC; 2004:12-14.
27. McLaughlin JK, Lindblad P, Mellemgaard A, et al. International renal-cell cancer study. I. Tobacco use. Int J Cancer. 1995;60:194-198.
28. Moore LE, Wilson RT, Campleman SL. Lifestyle factors, exposures, genetic susceptibility, and renal cell cancer. Cancer Invest. 2005;23:240-255.
29. Fukuzawa R, Anaka MR, Heathcott RW, et al. Wilms tumor histology is determined by distinct types of precursor lesions and not epigenetic changes. J Pathol. 2008;215:377-387.
30. Fukuzawa R, Reeve AE. Molecular pathology and epidemiology of nephrogenic rests and Wilms tumors. J Pediatr Hematol Oncol. 2007;29:589-594. (Pubitemid 47367992)
31. Breslow NE, Beckwith JB, Perlman EJ, et al. Age distribution, birth weights, nephrogeneic rests, and heterogeneity in the pathogenesis of Wilms tumor. Pediatr Blood Cancer. 2006; 47:260-267.
32. Hennigar RA, O'Shea PA, Grattan-smith JD. Clinicopatho-logic features of nephrogenic rests and nephroblastomatosis. Adv Anat Pathol. 2001;8:276-289.
33. Coppes MJ, Arnold M, Beckwith JB, et al. Factors affecting the risk of contralateral Wilms tumor development. A report from the National Wilms Tumor Study Group. Cancer. 1999;85:1616-1625. (Pubitemid 29152837)
34. Breslow NE, Collins AJ, Ritchey ML, et al. End stage renal disease in patients with Wilms tumor: results form the National Wilms Tumor Study group and the United States Data System. J Urol. 2005;174:1972-1975.
35. Baudoin P, Proovoost AP, Molenaar JC. Renal function up to 50 years after unilateral nephrectomy in childhood. Am J Kidney Dis. 1993;21:603-611. (Pubitemid 23178475)
36. Ellis LB, Weiss S. The renal function in persons with one kidney. Am J Med Sci. 1933;186:242-248.
37. Hamilton DNH, Reid WA. Yu Yu Voronoy and the first human kidney transplant. Surg Gynecol Obstet. 1984;159:289-294.
38. Hume DM, Merrill JP, Miller BF, et al. Experiences with renal homotransplantations in the human: report of nine cases. J Clin Invest. 1955;34:327-382.
39. Barry JM, Murray JE. The first human renal transplants. J Urol. 2006;176:888-890.
40. Ibrahim HN, Foley R, Tan L, et al. Long term consequences of kidney donation. N Engl J Med. 2009;260:459-469.
41. Rosenblatt GS, Nakamura N, Barry JM. End-stage renal disease after kidney donation: a single-center experience. Transplant Proc. 2008;40:1315-1318. (Pubitemid 351853170)
42. Soneji ND,Vyas J, Papalois VE. Long-term donor outcomes after living kidney transplant. Exp Clin Transplant. 2009;6: 215-223.
43. Sugaya K, Ogawa Y, Hatano T, et al. Compensatory renal hypertrophy and changes of renal function following ne-phrectomy. Acta Urol Jpn. 2000;46:235-240.
44. Levin A. Clinical epidemiology of cardiovascular disease in chronic kidney disease prior to dialysis. Semin Dial. 2003;16: 101-105. (Pubitemid 37361072)
45. Peces R, Martinez-Ara J, Miguel JL, et al. Renal cell carcinoma co-existent with other renal diseases: clinicopathologic features in pre-dialysis patients and those receiving dialysis or renal transplantation. Nephrol Dial Transplant. 2004;19:2789-2796. (Pubitemid 39480974)
46. Bijol V, Mendez GP, Hurwitz S, et al. Evaluation of the nonneoplastic pathology in tumor nephrectomy specimens. Predicting the risk of progressive renal failure. Am J Surg Pathol. 2006;30:575-584. (Pubitemid 44265009)
47. Henriksen KJ, Meehan SH, Chang A. Non-neoplastic renal diseases are often unrecognized in adult tumor nephrectomy specimens. A review of 246 cases. Am J Kidney Dis. 2007;31: 1703-1708. (Pubitemid 350287568)
48. Truong LD, Shen SS, Park M, et al. Diagnosing nonneo-plastic lesions in nephrectomy. Arch Pathol Lab Med. 2009; 133:189-200.
49. Bonsib SM. Renal lymphatics, and lymphatic involvement in sinus invasive (pT3b) clear cell renal cell carcinoma: a study of 40 cases. Mod Pathol. 2006;19:746-753.
50. Ishikawa Y, Aida S, Tamai S, et al. Significance of lymphatic invasion and proliferation on regional lymph node metastases in renal cell carcinoma. Am J Clin Pathol. 2007;128:198-207. (Pubitemid 47262617)
51. Kerjaschki D, Regele HM, Moosberger I, et al. Lymphatic neoangiogenesis in human kidney transplants is associated with immunologically active lymphatic infiltrates. J Am Soc Nephrol. 2005;15:603-612. (Pubitemid 38294790)
52. Stuht S, Gwinner W, Franz I, et al. Lymphatic neoangiogen-esis in human renal allografts: results from sequential protocol biopsies. Am J Transplant. 2007;7:377-384. (Pubitemid 46096330)
53. Bonsib SM. Renal veins and venous invasion in clear cell renal cell carcinoma. Mod Pathol. 2007;20:44-53. (Pubitemid 44967949)
54. Bonsib SM. The renal sinus is the principal invasive pathway. A prospective study of 100 renal cell carcinomas. Am J Surg Pathol. 2004;12:1594-1600.
55. Habib R, Gubler M, Antignac C, et al. Diffuse Mesangial Sclerosis: a congenital glomerulopathy with nephrotic syndrome. Adv Nephrol. 1993;22:43-57. (Pubitemid 20122520)
56. Schumacher V, Scharer K, Wuhl E, et al. Spectrum of early onset nephrotic syndrome associated with WT1 missense mutations. Kidney Int. 1998;53:1504-1600. (Pubitemid 28243741)
57. Niaudet P, Gubler M. WT1 and glomerular diseases. Pediatr Nephrol. 2006;21:1653-1660. (Pubitemid 44390829)
58. Dahan K, Kamal M, Noel L, et al. Small glomeruli in WAGR (Wilms tumor, aniridia, genitourinary anomalies and mental retardation) syndrome. Am J Kidney Dis. 2007;49:793-800. (Pubitemid 46802928)
59. Fischbach BV, Trout KL, Lewis J, et al. WAGR syndrome: a clinical review of 54 cases. Pediatrics. 2005;116:984-988. (Pubitemid 44542829)
60. Grundy PE, Breslow NE, Li S, et al. Loss of heterozygosity for chromosomes 1p and 16q is an adverse prognostic factor in favorable-histology Wilms tumor: a report from the National Wilms Tumor Study Group. J Clin Oncol. 2005;23:7312-7321. (Pubitemid 46205952)
61. Henigar RA, O'Shea PA, Grattan-Smith JD. Clinicopatho-logic features of nephrogenic rests and nephroblastoma. Adv Anat Pathol. 2001;8:276-289.
62. Coppes MJ, Arnold M, Beckwith JB, et al. Factors affecting the risk of contralateral Wilms tumor development. Cancer. 1999;85:1616-1625.
63. Habib R, Loriat C, Gubler MC, et al. The nephropathy associated with male pseudohermaphroditism and Wilms tumor (Drash syndrome): a distinctive glomerular lesion-report of 10 cases. Clin Nephrol. 1985;24:269-278. (Pubitemid 16186426)
64. Habib R. Nephrotic syndrome in the 1st year of life. Pediatr Nephrol. 1993;7:347-353. (Pubitemid 23258857)
65. Merta M, Reitorova J, Krkavcova J, et al. Focal segmental glomerulosclerosis in solitary kidney with WAGR syndrome. Prague Med Rep. 2004;105:69-73.
66. Malik K, Yan P, Huang TH, et al. Wilms' tumor: a paradigm for the new genetics. Oncol Res. 2000;12:441-449. (Pubitemid 33791804)
67. Dahan K, Kamal M, Noel LH, et al. Small glomeruli in WAGR (Wilms tumor, aniridia, genitourinary anomalies and mental retardation) syndrome. Am J Kidney Dis. 2007;49:793-880. (Pubitemid 46802928)
68. Breslow NE, Takashima JR, Ritchey ML, et al. Renal failure in the Densy-Drash and Wilms tumor-aniridia syndromes. Cancer Res. 2000;60:4030-4032.
69. Sommers SC. Renal pathology of essential hypertension. Am J Hypertens. 1990;3:583-587.
70. Schwartz GL, Strong CG. Renal parenchymal involvement in essential hypertension. Med Clin North Am. 1987;71:843-858. (Pubitemid 18015616)
71. Kashgarian M. Pathology of small blood vessels in hypertension. Am J Kidney Dis. 1985;5:A104-A110. (Pubitemid 15111808)
72. McManus JFA, Lupton CH Jr. Ischemic obsolescence of renal glomeruli. Lab Invest. 1960;9:413-434.
73. Zhou XJ, Rakheja D, Yu X, et al. The aging kidney. Kidney Int. 2008;74:710-720.
74. Nakamura S, Ishibashi-Ueda H, Niizuma S, et al. Coronary calcification in patients with chronic kidney disease and coronary artery disease. Clin J Am Soc Nephrol. 2009;4: 1892-1900.
75. Amann K. Media calcification and intima calcification are distinct entities in chronic kidney disease. Clin J Am Soc Nephrol. 2009;4:1599-1605.
76. Ruggenenti P, Remuzzi G. Nephropathy of type-2 diabetes mellitus. J Am Soc Nephrol. 1998;9:2157-2169. (Pubitemid 28482168)
77. Osterby R. Structural changes in type 1 (insulin-dependent) diabetes mellitus: causes, consequences, and prevention. Diabetologica. 1992;35:803-812.
78. Drummond K, Mauer M. The early natural history of nephropathy in type 1 diabetes II. Early renal structural changes in type I diabetes. Diabetes. 2002;51:1580-1587. (Pubitemid 34826628)
79. Stout LC, Kumar S, Whorton EB. Insudative lesions\their pathogenesis and association with glomerular obsolescence in diabetes: a dynamic hypothesis based upon single views of advancing human diabetic nephropathy. Hum Pathol. 1994;25:1213-1227. (Pubitemid 24351506)
80. Stout LC, Kumar S, Whorton EB. Focal mesangiolysis and the pathogenesis of the Kimmelstiel-Wilson Nodule. Hum Pathol. 1993;24:77-89. (Pubitemid 23046676)
81. Burchfiel CM, Tracy RE, Chyou P, et al. Cardiovascular risk factors and hyalinization of renal arterioles at autopsy. The Honolulu Heart Program. Arterioscler thromb Vasc Biol. 1997;17:760-768. (Pubitemid 27169140)
82. Bonsib SM. Renal neoplasms and cystic kidney diseases. Clin J Am Soc Nephrol. 2009;4:1998-2007.
83. Truong LD, Choi Y-J, Shen SS, et al. Renal cystic neoplasms and renal neoplasms associated with cystic renal diseases: pathogenetic and molecular links. Adv Anat Pathol. 2003;10: 135-159.
84. Fick GM, Gabow PA. Hereditary and acquired cystic disease of the kidney. Kidney Int. 1994;46:951-964. (Pubitemid 24319931)
85. Merino M, Eccles DM, Linehan WM, et al. Familial renal cell carcinoma. In: Eble JN, Sauter G, Epstein JI, et al. eds. The WHO Classification of Tumours of the Urinary System and Male Genital Organs. Lyon: IARC; 2004:15-22.
86. Walters W, Braasch WF. Surgical aspects of polycystic kidney. Surg Obstet Gynecol. 1934;58:647-650.
87. Hemal AK, Khaitan A, Singh I, et al. Renal cell carcinoma in cases of adult polycystic kidney disease: changing diagnostic and therapeutic implications. Urol Int. 2000;64:9-12. (Pubitemid 30224034)
88. Keith DS, Torres VE, King BF, et al. Renal cell carcinoma in autosomal dominant polycystic kidney disease. J Am Soc Nephrol. 1994;4:1661-1669.
89. Hatano T, Koyama Y, Hayakawa M, et al. Evidence for association between renal cell carcinomas and renal cystic diseases: nationwide survey in Japan. Nippon Hinyokika Gakkai Zasshi. 1996;87:1297. (Pubitemid 27043506)
90. Webb DW, Kabala J, Osborne JP. A population study of renal disease in patients with tuberous sclerosis. Br J Urol. 1994;74:151-154. (Pubitemid 24282757)
91. Cook JA, Oliver K, Mueller RF, et al. A cross sectional study of renal involvement in tuberous sclerosis. J Med Genet. 1996;33:480-484. (Pubitemid 26169330)
92. O'Callaghan FJ, Noakes MJ, Martyns CN, et al. An epidemiologic study of renal pathology in tuberous sclerosis complex. Br J Urol. 2004;94:853-857. (Pubitemid 39472484)
93. Rakowski SK, Winterkorn EB, Paul E, et al. Renal manifestations of tuberous sclerosis complex incidence, prognosis and predictive factors. Kidney Int. 2006;70: 1777-1782. (Pubitemid 44684809)
94. Breysem L, Nijs E, Proesmans W, et al. Tuberous sclerosis with cystic renal disease and multifocal renal cell carcinoma in a baby girl. Pediatr Radiol. 2002;32:677-680. (Pubitemid 36067717)
95. Duffy K, Al-Saleem T, Karbowniczek M, et al. Mutational analysis of the von Hippel Lindau gene in clear cell renal cell carcinoma from tuberous sclerosis complex patients. Mod Pathol. 2002;15:205-210. (Pubitemid 34246617)
96. Al-Saleem T, Wessner LL, Scheithauer BW, et al. Malignant tumors of the kidney, brain and soft tissues in children and young adults with the tuberous sclerosis complex. Cancer. 1998;83:2208-2216. (Pubitemid 28525404)
97. Bjornsson J, Short MP, Kwiatkowski DJ, et al. Tuberous sclerosis-associated renal cell carcinoma. Clinical, pathological, and genetic features. Am J Pathol. 1996;149:1201-1208. (Pubitemid 26337239)
98. Pea M, Bonetti F, Martignoni G, et al. Apparent renal cell carcinoma in tuberous sclerosis are heterogeneous. Am J Surg Pathol. 1998;22:180-187.
99. Martignoni G, Pea M, Bonetti F, et al. Carcinoma-like monotypic epithelioid angiomyolipoma in patients without evidence of tuberous sclerosis. Am J Surg Pathol. 1998;22: 663-672.
100. Eble JN, Amin MB, Young RH. Epithelioid angiomyolipoma of the kidney: a report of five cases with a prominent and diagnostically confusing epithelioid smooth muscle component. Am J Surg Pathol. 1997;21:1123-1130. (Pubitemid 27422310)
101. Svec A, Velenska Z. Renal epithelioid angiomyolipoma-a close mimic ofrenal cell carcinoma. Report of a case and review of the literature. Pathol Res Pract. 2005;200:851-856. (Pubitemid 40220971)
102. Bernstein J, Robbins TO. Renal involvement in tuberous sclerosis. Ann N Y Acad Sci. 1991;615:36-49.
103. Bernstein J, Robbins TO, Kissane JM. The renal lesions of tuberous sclerosis. Semin Diagn Pathol. 1986;3:97-105. (Pubitemid 16030816)
104. Bernstein J. Renal cystic disease in the tuberous sclerosis complex. Pediatr Nephrol. 1993;7:490-495. (Pubitemid 23258886)
105. Ong ACM, Harris PC, Davies DR, et al. Polycystin-1 expression in PKD1, early-onset PKD1 and TSC/PKD1 cystic tissue. Kidney Int. 1998;56:1324-1333.
106. Martignoni G, Bonetti F, Pea M, et al. Renal disease in adults with TSC2/PKD1 contiguous gene syndrome. Am J Surg Pathol. 2002;26:198-205. (Pubitemid 34127499)
107. Consugar MB, Wong WC, Lundquist PA, et al.; for the CRISP Consortium. Characterization of large rearrangements in autosomal dominant polycystic kidney disease and the PKD1/TSC1 contiguous gene syndrome. Kidney Int. 2008;74:1468-1479.
108. Shehata BM, Stockwell CA, Castellano-Sanchez AA, et al. von Hippel-Lindau (VHL) disease: an update on the clinico-pathologic and genetic aspects. Adv Anat Pathol. 2008;15: 165-171. (Pubitemid 351591499)
109. Neumann HPH, Zbar B. Renal cysts, renal cancer and von Hippel-Lindau disease. Kidney Int. 1997;51:16-26. (Pubitemid 27064517)
110. Poston CD, Jaffe GS, Lubensky IA, et al. Characterization of the renal pathology of a familial form of renal cell carcinoma associated with von-Hippel-Lindau disease: clinical and molecular genetic implications. J Urol. 1995;153:22-26.
111. Chauveau D, Duvic C, Chretien Y, et al. Renal involvement in von-Hippel-Lindau disease. Kidney Int. 1996;50:944-951.
112. Solomon D, Schwartz A. Renal pathology in von Hippel-Lindau disease. Hum Pathol. 1988;19:1072-1079.
113. Dunnill MS, Millard PR, Oliver D. Acquired cystic disease of the kidneys: a hazard of long-term intermittent hemodialysis. J Clin Pathol. 1977;30:868-877. (Pubitemid 8194693)
114. Miller LR, Soffer O, Nasser VH, et al. Acquired renal cystic disease in end-stage renal disease: an autopsy study. Am J Nephrol. 1989;9:868-877. (Pubitemid 19210569)
115. Matson MA, Cohen EP. Acquired cystic kidney disease: occurrence, prevalence, and renal cancers. Medicine. 1990;69: 217-226. (Pubitemid 20225989)
116. Takahashi S, Shirai T, Ogawa K, et al. Renal cell adenomas and carcinoma in hemodialysis patients: relationship between hemodialysis period and development of lesions. Acta Pathol Jpn. 1993;43:674-682. (Pubitemid 2011597)
117. Denton MD, Magee CC, Ovuworie C, et al. Prevalence of renal cell carcinoma in patients with ESRD pre-transplanta-tion: a pathologic analysis. Kidney Int. 2002;61:2201-2209. (Pubitemid 34539338)
118. Neuzillet Y, Lay F, Luccioni A, et al. De novo renal cell carcinoma of native kidneys in renal transplant recipients. Cancer. 2005;102:251-257. (Pubitemid 40129283)
119. Kojima Y, Takahara S, Miyake O, et al. Renal cell carcinoma in dialysis patients: a single center experience. Int J Urol. 2006;13:1045-1048. (Pubitemid 44125674)
120. Farivar-Mohseni H, Perlmutter AE, Wilson S, et al. Renal cell carcinoma and end stage kidney. J Urol. 2006;175: 2018-2021. (Pubitemid 43668544)
121. De Oliveira Costa MZ, Bacchi CE, Franco M. Histogenesis of the acquired cystic kidney disease. Appl Immunohistochem Mol Morphol. 2006;14:348-352.
122. Nadasdy T, Laszik Z, Lajoie G, et al. Proliferative activity of cyst epithelium in human renal cystic disease. J Am Soc Nephrol. 1995;5:1462-1468.
123. Cheuk W, Lo ESF, Chan AKC, et al. Atypical epithelial proliferations in acquired renal cystic disease harbor cytoge-netic aberrations. Hum Pathol. 2002;33:761-765. (Pubitemid 34953357)
124. Tickoo SK, dePeralta-Venturina MN, Harik LR, et al. Spectrum of epithelial neoplasms in end-stage renal disease. an experience for 66 tumor-bearing kidneys with emphasis on histologic patterns distinct form those in sporadic adult renal neoplasia. Am J Surg Pathol. 2006;30:141-153.
125. Dry SM, Renshaw AA. Extensive calcium oxalate crystal deposition in papillary renal cell carcinoma. Report of two cases. Arch Pathol Lab Med. 1998;122:260-261.
126. Rioux-Leclercq NC, Epstein JI. Renal cell carcinoma with intratumoral calcium oxalate crystal deposition in patients with acquired renal cystic disease of the kidney. Arch Pathol Lab Med. 2003;127:e89-e92.
127. Sule N, Yakupoglu U, Shen S, et al. Calcium oxalate deposition in renal cell cardinoma associated with acquired cystic kidney disease. Am J Surg Pathol. 2005;29:443-451. (Pubitemid 40411174)
128. Cossu-Rocca P, Eble JN, Zhang S, et al. Acquired cystic disease-associated renal tumors: an immunohistochemical and fluorescence in situ hybridization study. Mod Pathol. 2006;19:780-787. (Pubitemid 43780447)
129. Mallofre C, Almirall J, Campistol JM, et al. Acquired renal cystic disease in HD: a study of 82 nephrectomies in young patients. Clin Nephrol. 1992;37:297-302.
130. Tantatravahi J, Steinman TI. Acquired cystic kidney disease. Semin Dial. 2000;13:330-334.
131. Collins J, Kasiske B, Herzig C, et al. Excerpts from the United States Renal Data System 2004 annual data report: atlas of end stage renal disease in the United States. Am J Kidney Dis. 2006;17:S86-S89. (Pubitemid 43000353)
132. Srigley JR, Amin MB, Campbell SC, et al., for the members of the Cancer Committee, College of American Pathologists. Protocol for the Examination of Specimens from Patients with Invasive Carcinoma of Renal Tubular Origin''. Posted October 2009, CAP website.
133. Hill DA, Amin MB, Bowen J, et al., for the members of the Cancer Committee, College of American Pathologists. Protocol for the Examination of Specimens from Pediatric Patients with Wilms Tumors. Posted October 2009, CAP website.
134. Higgins JP, McKenney JK, Brooks JD, et al. Recommendations for the reporting of surgically resected specimens of renal cell carcinoma. Am J Clin Pathol. 2009;131:623-639.